Smart Equity Invest

← Results dashboard

Q2 FY27 · NSE: FAIRCHEMOR

Fairchem Organics

Results filed 22 October 2026 · Market cap ₹801 crore · PE 32.7

GrowthGuidance maintainedTranscript read

Revenue
+49.7%
on a year ago
EBITDA
+319.4%
on a year ago
Profit to shareholders
+1220.8%
on a year ago
EBITDA margin
10.5%
+0.4 pts on last quarter

Fairchem Organics reported Q2 FY27 revenue of Rs. 167 crore, reflecting a 49.7% YoY increase, while EBITDA margins recovered to 10.51% due to reduced Chinese dumping and higher product realizations. The company continues to operate at a modest 60% to 65% capacity utilization, with expectations to increase utilization by 5% quarterly as duty cuts on crude soybean oil enhance raw material availability. High shipping freight rates and weak European demand are delaying the company's export expansion into the US and European cosmetics markets.

Fairchem Organics Limited, Q2 FY27₹ crore, standalone
Q2 FY27Q1 FY27vs previous quarterQ2 FY26vs a year ago
Revenue167176−5.2%112+49.7%
Operating profit (EBIT)14.6815.13−3.0%1.41+941.1%
Operating margin8.8%8.6%+21 bps1.3%+753 bps
Other income0.150.35−57.1%0.37−59.5%
Exceptional items00–0–
Profit before exceptional items and tax13.6513.64+0.1%1.18+1056.8%
Profit to shareholders10.1710.01+1.6%0.77+1220.8%
Earnings per share (₹)8.077.95+1.5%0.59+1267.8%

Source: Fairchem Organics Limited’s filing to NSE, 22 October 2026. Operating profit is revenue less every expense except interest, so it leaves out other income and exceptional items. n.m.: not meaningful, because the earlier figure was zero or negative, or the latest one is a loss.

What stood out

  • Sharp margin rebound from a low base driven by lower Chinese dumping and higher product realizations
    SourceEBITDA margin expanded 674 bps YoY from 3.77% to 10.51% as realization rose from Rs. 106/kg in Q2 FY26 to Rs. 135/kg in Q2 FY27 (Transcript p. 5, Presentation p. 16).
  • Related-party land acquisition of Rs. 12 crore from promoter
    SourceCFO Bhavesh Shah noted: 'This land was already in use for our current operations... as well as our workers’ colony... And we thought of buying it from our promoter' for Rs. 12 crores (Transcript p. 8).
  • Working capital strain with trade receivables crossing Rs. 100 crore
    SourceTrade receivables rose to Rs. 1,002 Mn in H1 FY27 from Rs. 681 Mn in FY26 (Presentation p. 19), while CFO stated working capital cycle is 90 to 100 days (Transcript p. 9).

Guidance

MetricGuidancePeriod
Capacity utilization growth
SourceNahoosh Jariwala: 'every quarter, we expect 5% capacity improvement' (Transcript p. 13).
5% improvement per quarter towards 85%-90%Quarterly going forward
Quarterly revenue growth
SourceNahoosh Jariwala: 'we will try to achieve 5% to 10% growth every quarter' (Transcript p. 12).
5% to 10% growth every quarterQuarterly
EBITDA Margin aspiration
SourceNahoosh Jariwala: 'we should be able to maintain this margin... I would love to see 15%-18%' (Transcript p. 11).
Aiming to maintain current ~10.5% levels and aspire for 15% to 18% as utilization risesMedium term

Tailwinds

  • Relief in raw material duty structure improves domestic feed supply
    SourceImport duty reduction on Crude Soybean Oil from 16.5% to 11% improves oil availability from domestic refiners and softens input prices (Transcript p. 3, 4).
  • Reduced Chinese dumping supports domestic realization
    SourceReduction in Chinese export incentives and rupee depreciation reduced Chinese dumping of dimer acid in India, improving sales realizations to Rs. 135/kg (Transcript p. 5, 8).
  • Operational cost optimization initiatives completed
    SourceEnergy savings achieved through an in-depth energy audit and substitution of imported catalyst with domestic catalyst (Presentation p. 21, Transcript p. 11).

Headwinds

  • High freight costs stalling US export ramp-up
    SourceSpadework complete, but high container shipping freight costs from India to the US prevent commencement of exports (Transcript p. 6).
  • Sluggish demand in European cosmetics market
    SourceEuropean market slowdown and geopolitical issues are dampening Isostearic Acid adoption in cosmetics in the near term (Transcript p. 9, 13).
  • Underutilized manufacturing capacity
    SourcePlant operates at only 60% to 65% utilization due to past raw material availability constraints (Transcript p. 5, 12).

New businesses and products

new product · Plant erected but undergoing modifications based on R&D inputs; commissioning expected in Q3 FY27 post-Diwali

New Fatty Acid derivative product via novel technology

Expected benefit
Addresses a large market with import substitution and export potential
Risks
Hiccups expected during initial commissioning due to novel process and technology
Timeline
Q3 FY27 (October-December quarter)
Investment
Small capacity plant already put up; larger capex planned if product succeeds
SourceNahoosh Jariwala: 'we have put up a small capacity plant and which we expect to commence in October-December quarter. After Diwali, we expect it to start... it's a novel technology, novel process, and so it is going to take its own time' (Transcript p. 7, 13).

new product · Commercialized

Bypass fat from Palm Fatty Acid Distillate (PFAD)

Expected benefit
Value-added oleochemical product utilizing palm oil by-products
Timeline
Commercialized
SourceNahoosh Jariwala confirmed: 'Yes, it has been commercialized' (Transcript p. 7, Presentation p. 21).

new geography · Spadework and customer approvals completed, but US shipments delayed by high freight rates and European sales slowed by market conditions

Global export expansion for Isostearic Acid and prime products

Expected benefit
Targeting to raise export share initially to 25% and eventually to 50% of total sales
Risks
High shipping freight rates to US and macroeconomic/geopolitical slowdown in Europe
Timeline
When freight rates and European market stabilize
SourcePresentation p. 21 and Nahoosh Jariwala: 'we have done all the spadework for our US exports because of the too high freight cost to US from India, things are not moving as expected' (Transcript p. 6).

Things to check

  • Profit grew far faster than operating profit: other income, tax or one-offs did some of the work
  • Year-ago margin under 5%: growth from a low base
  • Related-party asset purchase of Rs. 12 crore from promoter
    SourceManagement confirmed purchasing land worth Rs. 12 crores from the promoter that was previously used for operations and a workers' colony (Transcript p. 8).
  • Sharp increase in trade receivables relative to revenue
    SourceTrade receivables rose 47% from Rs. 681 Mn in FY26 to Rs. 1,002 Mn in H1 FY27, increasing working capital requirements (Presentation p. 19).

How the call went

Management answered operational and volume-related queries clearly, acknowledging logistical and export market headwinds, but deflected details on feed composition and provided little detail on the new product's chemical composition.

Specific or vague
Provided clear metrics on capacity utilization (60-65%), realizations (Rs. 135/kg), and working capital days (90-100), but was non-specific on the exact chemistry of new products and refused to disclose raw material mix.
Candour
Management was forthright about near-term headwinds in Europe, delays in US exports caused by elevated freight, and initial hiccups expected in the new technology plant.
The hard questions
Analysts probed the related-party land transaction, margin sustainability, and Chinese competition; answers were brief and direct on the land transaction, though somewhat evasive regarding the raw material mix.

What analysts pressed on

  • Sustainability of 14%-18% EBITDA margins following import duty adjustments
  • Impact of high container freight costs and European demand slowdown on export rollouts
  • Justification and purpose of the Rs. 12 crore land purchase from the promoter
  • Timeline to scale capacity utilization from 60%-65% to 85%-90%

Answers that sidestepped

  • Refused to reveal the proportion of soybean vs other crude oils in their raw material feed: 'It would be good if we don't share our raw material combination' (Transcript p. 11).
  • Deflected on China's edible oil import duties: 'Oh, to be frank, next time we will check it out' (Transcript p. 5).

Numbers against the story

Management attributed H1 FY27 revenue growth (+41.4% YoY) primarily to higher price realizations resulting from higher raw material costs and reduced Chinese dumping. However, the reported numbers indicate that while EBITDA rose 316.7% YoY in Q2, sequential top-line declined from Rs. 176 crore in Q1 FY27 to Rs. 167 crore in Q2 FY27. Management highlighted strong export potential, but acknowledged in the call that actual export execution in the US and Europe is currently blocked by freight costs and soft demand.

Sources

Notes written by gemini-3.8-flash from the documents above on 15 November 2026. They summarise what the company said and can contain mistakes: check the source passage before relying on a point. Not investment advice.